Brian Haynes

Company: Bio-Techne Corporation

Job title: Chief Scientific Officer & Head of Bioinformatics, Molecular & Diagnostics Division

Seminars:

ESR1 & Beyond: Leveraging Exosomes for Highly Sensitive LBx Solutions 3:00 pm

Exosomes enable more complete and sensitive disease detection than cfDNA alone with unparalleled sensitivity (<0.1%VAF) to detect ESR1 mutations on widely available instruments. The QuantideX® qPCR ESR1 exoMutation Kit (RUO) combines co-enrichment of ctDNA and exosomal RNA, qPCR reagents, and automated push-button software for a complete LBx solution for clinical research laboratories everywhere.Read more

day: Day One Track A (1)